| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.00013 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.00011 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 7.5e-05 | 1 |